AIM:To optimize a xeno-free cry�opreservation protocol for primary� human hepatocy�tes.
METHODS:The demand for cry�opreserved hepatocy�tes is increasing for both clinical and research purposes. Despite several hepatocy�te cry�opreservation protocols being available, improvements are urgently� needed. We first compared controlled rate freezing to poly�sty�rene box freezing and did not find any� significant change between the groups. Using the poly�sty�rene box freezing, we compared two xeno-free freezing solutions for freezing of primary� human hepatocy�tes: a new medium (STEM-CELLBANKER, CB), which contains dimethy�lsul-phoxide (DMSO) and anhy�drous dextrose, both permeating and non-permeating cry�oprotectants, and the frequently� used DMSO -University� of Wisconsin (DMSO-UW) medium. The viability� of the hepatocy�tes was assessed by� the try�pan blue exclusion method as well as a calcein-esterase based live-dead assay� before and calcein-esterase based live-dead assay� before and before and after cry�opreservation. The function of the hepatocy�tes hepatocy�tes was evaluated before and after cry�opreservation by� asbefore and after cry�opreservation by� assessing enzy�matic activity� of 6 major cy�tochrome P450 isoforms (CYPs): CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4 and CYP3A7.
RESULTS:The new cry�oprotectant combination preserved hepatocyte viability significantly better than the standard DMSO-UW protocol (P <� 0.01). There was 0.01). There was 0.01). There was no significant difference in viability estimation between both the try�pan blue (TB) and the Live-Dead Assay� methods. There was a correlation between viability� of fresh hepatocy�tes and the difference in cell viability� between CB and DMSO protocols (r 2 = 0.69) using the TB method. However, due to high within-group variability� in the activities of the major CYPs, any� statistical between-group differences were precluded. Cry�opreser-vation of human hepatocy�tes using the cry�oprotectant combination was a simple and xeno-free procedure y�ielding better hepatocy�te viability�. Thus, it may� be a better alternative to the standard DMSO-UW protocol. Estimating CYP activities did not seem to be a relevant way� to compare hepatocy�te function between different groups due to high normal variability� between different liver samples.
CONCLUSION:The cry�oprotectant combination may� be a better alternative to the standard DMSO-UW protocol in primary� human hepatocy�te cry�opreservation.May 27, 2012|Volume 4|Issue 5| WJH|www.wjgnet.com 176